Black Diamond Therapeutics Inc — Cash Flow (NASDAQ:BDTX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 52.15 M100.15 M85.08 M66.72 M62.3 M 51.46 M Cash from investing activities 281.69 M130.61 M53.37 M16.35 M16.97 M 48.18 M Cash from financing activities 214.94 M729 K177 K71.93 M25.55 M 341 K Free cash flow 52 M97.44 M84.89 M66.68 M62.3 M 51.46 M

ニュース

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

What Makes Black Diamond (BDTX) a New Strong Buy Stock

New Strong Buy Stocks for January 9th

このPayPalアナリストはもはや楽観的ではありません。木曜日のトップ5の格下げをご紹介します

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)

スティーフェル社、ブラックダイヤモンド・セラピューティクスの株式に対する「買い」評価を8ドルで維持

Stifel reiterates Buy rating on Black Diamond Therapeutics stock at $8

This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Black Diamond Therapeutic (NASDAQ:BDTX), EastGroup Properties (NYSE:EGP)

ブラックダイアモンドの肺がん治療薬、第2相試験データで60%の応答率を示す

Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data - Black Diamond Therapeutic (NASDAQ:BDTX)

シルバーティニブ、希少変異を持つ肺がん患者で60%の奏効率を示す

Silevertinib shows 60% response rate in lung cancer patients with rare mutations